[go: up one dir, main page]

YU152587A - MONOCLONE ANTIBODIES AND PEPTIDES USEFUL IN THE TREATMENT AND DIAGNOSIS OF HIV INFECTIONS - Google Patents

MONOCLONE ANTIBODIES AND PEPTIDES USEFUL IN THE TREATMENT AND DIAGNOSIS OF HIV INFECTIONS

Info

Publication number
YU152587A
YU152587A YU152587A YU152587A YU152587A YU 152587 A YU152587 A YU 152587A YU 152587 A YU152587 A YU 152587A YU 152587 A YU152587 A YU 152587A YU 152587 A YU152587 A YU 152587A
Authority
YU
Yugoslavia
Prior art keywords
peptides
treatment
hiv
diagnosis
infections
Prior art date
Application number
YU152587A
Other languages
Serbo-Croatian (sh)
Inventor
M.K. Shriver
Thomase
W.L. Cosand
L.H.. Gosting
E.S. Dickinson
J. Maclure
G.J. Todaro
R.C. Nowinski
Original Assignee
Genetics Systems Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Systems Corporation filed Critical Genetics Systems Corporation
Publication of YU152587A publication Critical patent/YU152587A/en

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00—Multi-stage pumps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • AIDS & HIV (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

MONOKLONSKA ANTITELA I PEPTIDI KORISNI U TRETIRANJU I DIJAGNOSTIFIKOVANJU HIV-INFEKCIJA. Pronalazak opisuje postupak za dobijanje peptida koji su sposobni da imunološki imitirju neutralizujuće epitope proteina iz HIV, nukleinsko-kiselinske probe koje kodiraju za takve peptide i monoklonska antitela koja su reaktivna sa takvim peptidima, kao i druge peptide koji utiču na infektivnost HIV. Ovi novi materijali nalaze primenu u, na primer, dijagnostičkim ispitivanjima za detekciju infekcije HIV i u terapijskim režimima za tretman takvih infekcija ili za vakcinaciju protiv njih.MONOCLONE ANTIBODIES AND PEPTIDES USEFUL IN THE TREATMENT AND DIAGNOSIS OF HIV INFECTIONS. The invention describes a process for preparing peptides capable of immunologically mimicking neutralizing epitopes of proteins from HIV, nucleic acid probes encoding such peptides and monoclonal antibodies reactive with such peptides, as well as other peptides affecting HIV infectivity. These new materials find application in, for example, diagnostic tests for the detection of HIV infection and in therapeutic regimens for the treatment of such infections or for vaccination against them.

YU152587A 1986-08-20 1987-08-17 MONOCLONE ANTIBODIES AND PEPTIDES USEFUL IN THE TREATMENT AND DIAGNOSIS OF HIV INFECTIONS YU152587A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29

Publications (1)

Publication Number Publication Date
YU152587A true YU152587A (en) 1992-09-07

Family

ID=27366600

Family Applications (1)

Application Number Title Priority Date Filing Date
YU152587A YU152587A (en) 1986-08-20 1987-08-17 MONOCLONE ANTIBODIES AND PEPTIDES USEFUL IN THE TREATMENT AND DIAGNOSIS OF HIV INFECTIONS

Country Status (28)

Country Link
JP (1) JPS6485928A (en)
KR (1) KR920008744B1 (en)
AT (1) AT398080B (en)
AU (1) AU616156B2 (en)
BE (1) BE1000811A4 (en)
CH (1) CH675728A5 (en)
CS (1) CS275838B6 (en)
DE (1) DE3727703A1 (en)
DK (1) DK433087A (en)
ES (1) ES2010727A6 (en)
FI (1) FI873553A (en)
FR (1) FR2603107B1 (en)
GB (1) GB2196634B (en)
GR (1) GR871298B (en)
HU (1) HU214439B (en)
IE (1) IE60671B1 (en)
IL (1) IL83580A (en)
IT (1) IT1222518B (en)
LU (1) LU86972A1 (en)
NL (1) NL8701950A (en)
NO (2) NO300462B1 (en)
NZ (1) NZ221440A (en)
OA (1) OA08652A (en)
PL (1) PL155084B1 (en)
PT (1) PT85567B (en)
SE (1) SE506025C2 (en)
YU (1) YU152587A (en)
ZW (1) ZW15487A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
DE3853779T2 (en) * 1987-05-29 1995-09-07 Baylor College Medicine HIV-1 NEUTRALIZING MONOCLONAL ANTIBODIES.
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
WO1989007112A1 (en) * 1988-01-26 1989-08-10 The United States Of America, As Represented By Th A synthetic antigen evoking anti-hiv response
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (en) * 1988-06-06 1992-04-10 Pasteur Institut PEPTIDES HAVING PROTECTIVE PROPERTIES OF A PATHOGENIC VIRUS OF THE HIV TYPE IN SENSITIVE CELLS
WO1990003984A1 (en) * 1988-10-03 1990-04-19 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
EP0421626A1 (en) * 1989-09-19 1991-04-10 Merck & Co. Inc. Vaccine for aids and hepatitis B
SE9000333D0 (en) * 1990-01-31 1990-01-31 Britta Wahren MONOCLONAL ANTIBODY
SE468168B (en) * 1990-02-20 1992-11-16 Replico Medical Ab HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS
JPH03271233A (en) * 1990-03-19 1991-12-03 Inst Pasteur Induction of protection against viral infection by synergy between viral envelope glycoproteins and peptides corresponding to neutralizing epitopes of the glycoproteins
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (en) * 1991-09-30 1993-11-22 Nitto Denko Corp Hiv-related cyclic peptide and adsorption material obtained by immobilizing the same
ATE267838T1 (en) * 1992-03-27 2004-06-15 Advanced Immuni T Inc T-PEPTIDE AND RELATED PEPTIDES IN THE TREATMENT OF INFLAMMATION INCLUDING MULTIPLE SCLEROSIS
EP1976548B1 (en) 2005-12-09 2014-07-02 Vectus Biosystems Limited VIP fragments and compositions thereof
EP2323233B1 (en) 2008-09-02 2017-10-11 NGK Spark Plug Co., Ltd. Spark plug
KR102727239B1 (en) * 2022-09-07 2024-11-07 한국세라믹기술원 Magnesium oxide powder and method for manufacturing the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
ES8705522A1 (en) * 1984-10-18 1987-05-01 Pasteur Institut A PROCEDURE FOR THE PREPARATION OF PURIFIED DERIVATIVES OF A GLYCOPROTEIN.
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
CA1341384C (en) * 1985-04-08 2002-08-20 Susan Mitsue Watanabe Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav
DK171119B1 (en) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS virus envelope protein, expression vector carrying the envelope protein, transformants transformed with the expression vector, method of producing the virus envelope protein, method of detecting AIDS antibodies, method of determining AIDS virus, vaccine against AIDS, antibodies against the virus envelope protein and use of it to prepare a vaccine and for testing
DE3650175T3 (en) * 1985-04-29 2007-09-06 Bio-Rad Laboratories, Inc., Hercules SYNTHETIC ANTIGENIC TO IDENTIFY AIDS.
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
JPS63501716A (en) * 1985-10-24 1988-07-14 サウスウエスト・ファウンデ−ション・フォア・バイオメディカル・リサ−チ Synthetic peptides and their use for diagnosis of AIDS and ARC and vaccine injections
WO1987002988A1 (en) * 1985-11-07 1987-05-21 President And Fellows Of Harvard College T-cell lymphotrophic virus protein and assay
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
EP0255190A3 (en) * 1986-08-01 1990-08-29 Repligen Corporation Recombinant polypeptides and their uses, inclusing assay for aids virus
EP0273716B1 (en) * 1986-12-30 1993-08-11 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins

Also Published As

Publication number Publication date
NO302176B1 (en) 1998-02-02
KR920008744B1 (en) 1992-10-09
CH675728A5 (en) 1990-10-31
SE8703225L (en) 1988-02-21
BE1000811A4 (en) 1989-04-11
FR2603107A1 (en) 1988-02-26
ES2010727A6 (en) 1989-12-01
NO934897D0 (en) 1993-12-29
NL8701950A (en) 1988-03-16
FI873553A (en) 1988-02-21
HUT44619A (en) 1988-03-28
IT1222518B (en) 1990-09-05
AU616156B2 (en) 1991-10-24
FI873553A0 (en) 1987-08-17
IT8721678A0 (en) 1987-08-19
AU7720187A (en) 1988-05-19
ZW15487A1 (en) 1988-09-14
IL83580A0 (en) 1988-01-31
JPS6485928A (en) 1989-03-30
IE60671B1 (en) 1994-08-10
NO873495L (en) 1988-02-22
NO934897L (en) 1993-12-29
IL83580A (en) 1992-11-15
GB2196634B (en) 1991-05-15
SE8703225D0 (en) 1987-08-19
CS275838B6 (en) 1992-03-18
NZ221440A (en) 1991-11-26
LU86972A1 (en) 1988-03-02
PT85567A (en) 1987-09-01
GR871298B (en) 1988-01-12
DK433087A (en) 1988-02-21
PL155084B1 (en) 1991-10-31
DE3727703A1 (en) 1988-05-05
PT85567B (en) 1991-02-08
OA08652A (en) 1988-11-30
CS8706136A2 (en) 1990-08-14
FR2603107B1 (en) 1992-04-24
NO300462B1 (en) 1997-06-02
KR890002547A (en) 1989-04-10
NO873495D0 (en) 1987-08-19
SE506025C2 (en) 1997-11-03
DK433087D0 (en) 1987-08-19
GB8719587D0 (en) 1987-09-23
HU214439B (en) 1998-03-30
IE872219L (en) 1988-02-20
GB2196634A (en) 1988-05-05
AT398080B (en) 1994-09-26
PL267401A1 (en) 1988-07-21
ATA208987A (en) 1994-01-15

Similar Documents

Publication Publication Date Title
YU152587A (en) MONOCLONE ANTIBODIES AND PEPTIDES USEFUL IN THE TREATMENT AND DIAGNOSIS OF HIV INFECTIONS
Young et al. Immunological activity of a 38-kilodalton protein purified from Mycobacterium tuberculosis
EP0214709B1 (en) Synthetic peptide and process of using same for the detection of antibodies to htlv-iii, diagnosis of aids and pre-aids conditions and as a vaccine
US4833071A (en) Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor
NZ219113A (en) Hiv peptide containing epitope of the env protein
HUP0002176A2 (en) Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
NO20002413D0 (en) Antibodies to Moraxella proteins and their use, as well as sets for the detection of antigen and pharmaceutical preparations containing antibodies
DK614987D0 (en) SYNTHETIC HTLV-III PEPTIDES, PREPARATIONS AND APPLICATIONS THEREOF
SE9102976D0 (en) HYBRID DNA VECTORS, SINGLE ORGANISMS AND BACTERIA FOR USE FOR PRODUCTION OF HIV PROTEINS AND PEPTIDES
KR900701836A (en) Peptides useful for diagnosing, preventing or treating new HIV proteins and AIDS
HUP0303134A2 (en) Hiv peptides, antigens, vaccine compositions, immunoassay kits and method of detecting antibodies induced by hiv
ATE238065T1 (en) PEPTIDES FOR USE IN VACCINATION AND STIMULATION OF ANTIBODIES AGAINST HUMAN IMMUNODEFICIENCY VIRUS
ATE442439T1 (en) MELANOMA ANTIGENE P15 AND THEIR APPLICATION IN DIAGNOSTIC AND THERAPEUTIC PROCEDURES
ATE206620T1 (en) HUMAN MONOCLONAL ANTIBODIES AGAINST HIV-1 TRANSMEMBRANE GLYCOPROTEIN (GP41), AND RELATED PEPTIDES
ATE159170T1 (en) VACCINES AND DIAGNOSTIC TEST FOR HAEMOPHILUS INFLUENZAE
ATE128716T1 (en) HIV PEPTIDES AND METHODS FOR DETECTING HIV.
ES2071626T3 (en) MONOCLONAL ANTIBODY OF THE MOUSE AGAINST THE PROTEIN GP41 OF THE VIRUSES OF HUMAN IMMUNODEFICIENCY.
ES2052370T3 (en) IMMUNOLOGICALLY ACTIVE PEPTIDES OR POLYPEPTIDES OF PARVOVIRUS B19.
ATE124420T1 (en) VACCINES AND TESTING KITS FOR HAEMOPHILUS INFLUENZAE.
JPH02500977A (en) New peptides and their uses
DE69017352D1 (en) Peptides related to HIV.
Batonick et al. Identification and characterization of mimotopes of classical swine fever virus E2 glycoprotein using specific anti-E2 monoclonal antibodies
DE69012989D1 (en) PEPTIDES OF RETINBLASTOMA GENE PRODUCTS AND ANTIBODIES AGAINST.
Hunt et al. Mouse monoclonal antibody 5-21-3 recognizes a contiguous, conformation-dependent epitope and maps to a hydrophilic region in HIV-1 gp41
Qu et al. Checkerboard immunoblotting recognizes twenty epitopes among the B subunit proteins of the cholera enterotoxin family